Masha Kocherginsky

11.3k total citations · 3 hit papers
185 papers, 7.2k citations indexed

About

Masha Kocherginsky is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Masha Kocherginsky has authored 185 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 45 papers in Molecular Biology and 44 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Masha Kocherginsky's work include Estrogen and related hormone effects (14 papers), Prostate Cancer Treatment and Research (12 papers) and Renal cell carcinoma treatment (11 papers). Masha Kocherginsky is often cited by papers focused on Estrogen and related hormone effects (14 papers), Prostate Cancer Treatment and Research (12 papers) and Renal cell carcinoma treatment (11 papers). Masha Kocherginsky collaborates with scholars based in United States, Canada and Italy. Masha Kocherginsky's co-authors include Serena Wu, Judith U. Hibbard, Suzanne D. Conzen, Everett E. Vokes, Theodore Karrison, Qiang Zhang, Deng Pan, James J. Dignam, Louise C. Hawkley and Mark J. Ratain and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.

In The Last Decade

Masha Kocherginsky

172 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Abnormal placentation: Twenty-year analysis

2005 896 citations Masha Kocherginsky et al. profile →
Genetic Variants in the UDP-glucuronosyltransferase 1A1 Gene Predict the Risk of Severe Neutropenia of Irinotecan

2004 695 citations Samir D. Undevia, Masha Kocherginsky et al. profile →
Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer

2018 455 citations Brandon-Luke L. Seagle, Emma L. Barber et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masha Kocherginsky United States	43	1.8k	1.7k	1.3k	1.2k	1.1k	185	7.2k
Jan Lindemans Netherlands	55	1.0k 0.6×	1.6k 0.9×	1.1k 0.8×	2.1k 1.8×	967 0.9×	217	9.9k
Allan Hackshaw United Kingdom	50	2.3k 1.3×	1.3k 0.8×	656 0.5×	3.4k 2.9×	1.7k 1.5×	202	10.7k
Anastasia Iliadou Sweden	33	1.1k 0.6×	1.4k 0.8×	442 0.3×	1.4k 1.2×	906 0.8×	85	6.3k
Wei Zhang China	50	1.8k 1.0×	4.2k 2.5×	1.9k 1.5×	839 0.7×	918 0.8×	373	10.4k
Clemens Tempfer Austria	52	1.9k 1.1×	1.9k 1.1×	1.9k 1.5×	676 0.6×	796 0.7×	374	9.2k
Joellen M. Schildkraut United States	51	1.7k 1.0×	2.3k 1.4×	1.2k 0.9×	1.1k 1.0×	623 0.6×	219	8.7k
Mats Lambe Sweden	62	4.9k 2.8×	1.4k 0.8×	661 0.5×	1.4k 1.2×	2.5k 2.2×	293	12.0k
Britton Trabert United States	41	1.8k 1.0×	2.0k 1.2×	1.2k 0.9×	404 0.3×	607 0.5×	173	7.7k
Anna L.V. Johansson Sweden	40	1.6k 0.9×	383 0.2×	803 0.6×	1.0k 0.9×	637 0.6×	128	5.3k
Marie‐Josèphe Horner United States	11	3.6k 2.1×	1.3k 0.8×	293 0.2×	774 0.7×	1.9k 1.7×	26	8.2k

Countries citing papers authored by Masha Kocherginsky

Since Specialization

Citations

This map shows the geographic impact of Masha Kocherginsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masha Kocherginsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masha Kocherginsky more than expected).

Fields of papers citing papers by Masha Kocherginsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masha Kocherginsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masha Kocherginsky. The network helps show where Masha Kocherginsky may publish in the future.

Co-authorship network of co-authors of Masha Kocherginsky

This figure shows the co-authorship network connecting the top 25 collaborators of Masha Kocherginsky. A scholar is included among the top collaborators of Masha Kocherginsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masha Kocherginsky. Masha Kocherginsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mulcahy, Mary F., Masha Kocherginsky, Howard S. Höchster, et al.. (2024). A phase II study of FOLFOX combined with nab-paclitaxel in the treatment of metastatic or advanced unresectable gastric, gastroesophageal junction adenocarcinoma: a Big Ten Cancer Research Consortium trial. The Oncologist. 29(12). 1044–1050. 1 indexed citations

Kocherginsky, Masha, et al.. (2023). Integrated Multi-Omic Analysis Reveals Immunosuppressive Phenotype Associated with Poor Outcomes in High-Grade Serous Ovarian Cancer. Cancers. 15(14). 3649–3649. 5 indexed citations

Sanders, Emily C., David Aaby, Alexander J. Barry, et al.. (2023). Development of a Remote Version of the Graded Redefined Assessment of Strength, Sensation, and Prehension (GRASSP): Validity and Reliability. Neurorehabilitation and neural repair. 37(2-3). 83–93. 1 indexed citations

Meghani, Khyati, Lauren Folgosa Cooley, Bonnie Choy, et al.. (2022). First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guérin. European Urology. 82(6). 602–610. 44 indexed citations

Barber, Emma L., Siqi Chen, Mario Javier Pineda, et al.. (2022). Clinical and Biological Activity of Chemoimmunotherapy in Advanced Endometrial Adenocarcinoma: A Phase II Trial of the Big Ten Cancer Research Consortium. Cancer Research Communications. 2(10). 1293–1303. 7 indexed citations

Goodman, Chelain R., Brandon-Luke L. Seagle, Masha Kocherginsky, et al.. (2018). 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer. Clinical Cancer Research. 24(16). 3878–3887. 33 indexed citations

West, Diana C., Deng Pan, Eva Tonsing-Carter, et al.. (2016). GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer Outcome. Molecular Cancer Research. 14(8). 707–719. 80 indexed citations

Skor, Maxwell N., Masha Kocherginsky, Anju Goyal, et al.. (2013). Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer. Clinical Cancer Research. 19(22). 6163–6172. 152 indexed citations

Volden, Paul A., Maxwell N. Skor, Christopher M. Carmean, et al.. (2013). Chronic Social Isolation Is Associated with Metabolic Gene Expression Changes Specific to Mammary Adipose Tissue. Cancer Prevention Research. 6(7). 634–645. 33 indexed citations

10.

Cohen, Ezra E.W., Kehua Wu, Christine Hartford, et al.. (2012). Phase I Studies of Sirolimus Alone or in Combination with Pharmacokinetic Modulators in Advanced Cancer Patients. Clinical Cancer Research. 18(17). 4785–4793. 51 indexed citations

11.

Ostler, Kelly R., Qiwei Yang, Timothy J. Looney, et al.. (2012). Truncated DNMT3B Isoform DNMT3B7 Suppresses Growth, Induces Differentiation, and Alters DNA Methylation in Human Neuroblastoma. Cancer Research. 72(18). 4714–4723. 32 indexed citations

12.

Dignam, James J., Qiang Zhang, & Masha Kocherginsky. (2012). The Use and Interpretation of Competing Risks Regression Models. Clinical Cancer Research. 18(8). 2301–2308. 261 indexed citations

13.

Pan, Deng, Masha Kocherginsky, & Suzanne D. Conzen. (2011). Activation of the Glucocorticoid Receptor Is Associated with Poor Prognosis in Estrogen Receptor-Negative Breast Cancer. Cancer Research. 71(20). 6360–6370. 210 indexed citations

14.

Kocherginsky, Masha, et al.. (2010). Autoimmunity in Patients with Resistance to Thyroid Hormone. The Journal of Clinical Endocrinology & Metabolism. 95(7). 3189–3193. 39 indexed citations

15.

Williams, James B., Diana Pang, Bertha Delgado, et al.. (2009). A Model of Gene-Environment Interaction Reveals Altered Mammary Gland Gene Expression and Increased Tumor Growth following Social Isolation. Cancer Prevention Research. 2(10). 850–861. 91 indexed citations

16.

Dougherty, Urszula, Masha Kocherginsky, Amikar Sehdev, et al.. (2009). Epidermal Growth Factor Receptor Is Required for Colonic Tumor Promotion by Dietary Fat in the Azoxymethane/Dextran Sulfate Sodium Model: Roles of Transforming Growth Factor- and PTGS2. Clinical Cancer Research. 15(22). 6780–6789. 30 indexed citations

17.

Yamada, S. Diane, Gini F. Fleming, Bertha Delgado, et al.. (2009). Administration of Glucocorticoids to Ovarian Cancer Patients Is Associated with Expression of the Anti-apoptotic Genes SGK1 and MKP1/DUSP1 in Ovarian Tissues. Clinical Cancer Research. 15(9). 3196–3204. 68 indexed citations

18.

Cohen, Ezra E.W., Hongyan Zhu, Mark W. Lingen, et al.. (2008). A Feed-Forward Loop Involving Protein Kinase Cα and MicroRNAs Regulates Tumor Cell Cycle. Cancer Research. 69(1). 65–74. 67 indexed citations

19.

Posner, Mitchell C., James O. Park, Thomas E. Darga, et al.. (2005). Progression of Barrett's Metaplasia to Adenocarcinoma Is Associated with the Suppression of the Transcriptional Programs of Epidermal Differentiation. Cancer Research. 65(8). 3146–3154. 133 indexed citations

20.

Armato, Samuel G., Geoffrey R. Oxnard, Heber MacMahon, et al.. (2004). Measurement of mesothelioma on thoracic CT scans: A comparison of manual and computer‐assisted techniques. Medical Physics. 31(5). 1105–1115. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact